Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TwHF and MTX in Rheumatoid Arthritis
NCT03324412Phase 3Unknown
- Sponsor
- Guang'anmen Hospital
- Start
- Oct 2017
- Primary completion
- May 2019
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Tripterygium wilfordii in rheumatoid arthritis (RA), sponsored by Guang'anmen Hospital. Status: unknown.
02
Drugs
Tripterygium wilfordii
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03324412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03324412.